Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study
Thyroid® · 2024
DOI: 10.1089/thy.2024.0073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thyroid®, 2024. Verfasst von Maryam Barzin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Hypothyroidism, Thyroxine, Hormone Replacement Therapy, Obesity, Morbid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Obesity and hypothyroidism are common medical conditions that are associated with each other. Bariatric surgery (BS) is a common approach used to achieve substantial weight loss in obese patients. However, there is limited evidence regarding the need for postsurgery levothyroxine (LT4) dose adjustment in patients with hypothyroidism undergoing BS.
Methods
This was a three-year prospective cohort study assessing postsurgery LT4 requirements with attention to body composition changes. The current study included 1030 patients with hypothyroidism, who underwent sleeve gastrectomy (SG) ( n = 707, 88.3% women) or one anastomosis gastric bypass (OAGB) ( n = 323, 92% women). Patients were followed for 36 months after surgery. A bioelectrical impedance analyzer was used for body composition assessment. LT4 requirements were assessed by generalized estimating equation (GEE) methods adjusted for weight as a time-varying covariate.
Results
During the follow-up, TSH (mIU/L) and T4 (ng/dL) measurements did not significantly change in the OAGB group over time. However, in the SG group, TSH measurement decreased over time ( p trend =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
- Department of Surgery, Faculty of Medicine, Tehran Obesity Treatment Center, Shahed University, Tehran, Iran.
- Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Fereidoun Azizi
Zitieren
APA
Barzin, M., Molavizadeh, D., Mahdavi, M., Khalaj, A., Sadeghi, S., Valizadeh, M., Azizi, F., & Hosseinpanah, F. (2024). Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study. Thyroid®. https://doi.org/10.1089/thy.2024.0073
Vancouver
Barzin M, Molavizadeh D, Mahdavi M, Khalaj A, Sadeghi S, Valizadeh M, et al. Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study. Thyroid®. 2024. doi:10.1089/thy.2024.0073
BibTeX
@article{Barzin2024,
author = {Barzin, Maryam and Molavizadeh, Danial and Mahdavi, Maryam and Khalaj, Alireza and Sadeghi, Sara and Valizadeh, Majid and Azizi, Fereidoun and Hosseinpanah, Farhad},
title = {Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study},
journal = {Thyroid®},
year = {2024},
doi = {10.1089/thy.2024.0073}
}
EUVIMED